General Surgery Critical Care Unit II

The SICU of our hospital was established and put into operation in 1992; it was one of the 5 ICU training bases in China established with direct support from the Ministry of Health at that time, and also one of the earliest ICUs in China dedicated specifically to the management of critically ill general-surgery patients. The SICU has 12 open beds. It currently has 11 physicians, including 1 professor and chief physician; 3 associate professors and deputy chief physicians, 4 lecturers and attending physicians; and 3 resident physicians. Six physicians have obtained or are pursuing doctoral or master’s degrees in medicine. Some physicians have studied or received further training in the United States, Hong Kong, and elsewhere. The SICU is currently the institution where the vice chair of the Critical Care Medicine Branch of the Chinese Medical Association serves, and where the chair of the Critical Care Medicine Branch of Guangdong Province serves. The SICU adheres to a patient-centered approach, works to build harmonious doctor–patient relationships, and successfully completes all medical performance targets every year. It mainly admits critically ill patients from surgery, obstetrics and gynecology, stomatology, and otorhinolaryngology. Conditions treated include sepsis, septic shock, hypovolemic shock, cardiogenic shock, obstructive shock, severe pneumonia, thymoma with myasthenic crisis, acute peritonitis, thoracic/abdominal aortic aneurysms, liver transplantation, kidney transplantation, cluster organ transplantation, and perioperative patients with organ dysfunction. All SICU physicians are proficient in commonly used and advanced critical care skills, including endotracheal intubation, central venous puncture, arterial puncture, fiberoptic bronchoscopy examination and treatment, SWAN-GANZ flotation catheter placement, PICCO technology, flow-occlusion monitoring technology, blood purification technology, etc. For all patients transferred to the SICU, close, dynamic, and accurate monitoring and timely, efficient treatment are provided. This ensures the smooth performance of difficult, complex, and critical surgeries in all specialties. Meanwhile, in clinical development, we actively implement and maintain our strengths in hemodynamic and oxygen metabolism monitoring, continuous bedside blood purification, SEPSIS early goal-directed therapy, and the development and application of new technologies and projects: ① neurally adjusted ventilatory assist (neurally adjusted ventilatory assist,NAVA) technology; ② HVHF (high-flow blood purification technology); ③ continuous cardiac output and SvO 2 monitoring technology as routine clinical monitoring; ④ targeted monitoring of catheter-related infections. In particular, the application of new technologies and theories in hemodynamic management, continuous renal replacement therapy (CRRT), oxygen metabolism management, airway management and mechanical ventilation, severe pancreatitis, and liver transplantation management is at the forefront in China. Over the past 3 years, the SICU has admitted an annual average of 800-900 critically ill surgical patients; critically ill patients accounted for 75-80%, and the rescue success rate for critically ill surgical patients reached 85-93%, providing full assurance for complex and critical surgeries. The SICU has become one of the windows into our hospital’s overall strength. Personnel: Department Director: 陈娟 Deputy Directors: 欧阳彬 陈敏英 Senior personnel: 蔡常洁 Associate senior personnel: 黄顺伟